NCT00456937

CompletedPhase 4

Escitalopram in Schizophrenia in OCD- Open Label Study

BeerYaakov Mental Health Center Source

Compare

Other study identifiers

Sponsor study identifier

Escitalopram-173CTIL

Study Type

interventional

Estimated enrollment

15

Locations

1 country

Sites

1

Timeline

Study Start

July 2006

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

September 2008

Actual (reported)

Study Completion

September 2008

Actual (reported)

Brief Summary

SSRI's has been demonstrated to be partially effective in schizophrenia and OCD. We therefore suggest that Escitalopram up to 20 mg /d in those patients could be effective in reducing obsessive compulsive symptomatology

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Estimated enrollment: 15 participants
Study completion date: September 2008
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Some registry-reported names shown below are not yet linked in this graph.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
July 2006
Date type not reported
This date has not been verified as actual or estimated.
First Submitted
December 3, 2006
Actual (reported)
First Posted
April 5, 2007
Actual (reported)
Primary Completion
September 2008
Actual (reported)
Study Completion
September 2008
Actual (reported)

Last Updated: January 27, 2009
Status Verified: January 2009
Last Update Submitted: January 26, 2009

Conditions

Schizophrenia

Interventions

EscitalopramDrug

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years - 65 Years

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

Patients who suffer from schizophrenia and OCD

You may not qualify if:

Sponsors & Collaborators

Lundbeck Israel
Industrycollaborator
BeerYaakov Mental Health Center
Governmentlead

Study Sites (1)

Beer Yaakov MHC

Beer Yaakov, 70350, Israel

MeSH Terms

Conditions

Schizophrenia

Interventions

Escitalopram

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental Disorders

Intervention Hierarchy (Ancestors)

PropylaminesAminesOrganic ChemicalsNitrilesBenzofuransHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic Compounds

Study Officials

Rafael Octavio Stryjer, M.D.
Beer Yaakov Mental Health Center
PRINCIPAL INVESTIGATOR

Study Design

Study Type: interventional
Phase: phase 4
Allocation: NON RANDOMIZED
Masking: NONE
Intervention Model: SINGLE GROUP
Sponsor Type: OTHER GOV

Study Record Dates

First Submitted

December 3, 2006

First Posted

April 5, 2007

Study Start

July 2006

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

September 2008

Actual (reported)

NCT00659919

Treatment of Neuroleptic Induced Acute Akathisia With Trazodone

Phase 4Completed

NCT00352339

The New Strategy for Pharmacological Treatment in People With Schizophrenia

Phase 4Unknown

NCT00650897

Efficacy Study of Escitalopram for Depression in Patients With Diabetes

Phase 4Unknown

NCT01133080

Minocycline as an Adjunctive Therapy for Schizophrenia: a Randomized Controlled Study

Phase 4Unknown

NCT00333177

Psychosocial Therapy and Risperidone Treatment in Work Performance in Recent-Onset Schizophrenia

Phase 4Completed

NCT00757978

Memantine as Adjunctive Therapy for Schizophrenia Negative Symptoms

Phase 4Completed

Substance abuse,

Serious medical condintions,

Being on SSRI treatment

Contact the study team to confirm eligibility.

Study Completion

September 2008

Actual (reported)

Last Updated

January 27, 2009

Record last verified: 2009-01

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT00456937
Data provider: ClinicalTrials.gov
Source updated: 2009-01-27
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:24:23 UTC

Locations

IL(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Intervention Hierarchy (Ancestors)

Study Officials

Study Design

Study Record Dates

Source record

Locations